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Sununary: Dipeptidyl peptidase IV (CD 26 leukocyte differentiation antigen) is an enzymic surface marker of
a human T lymphocyte subpopulation which has been shown to be associated with their capacity to produce
large amounts of interleukin 2 and proliferate strongly in response to mitogenic Stimulation. The peptidase
activity on the surface of purified human peripheral mononuclear cells was determined spectrophotometrically
with the Substrate glycyl-L-proline-4-nitranilide. The peripheral mononuclear cells of pregnant women exhib-
ited depressed mean dipeptidyl peptidase IV activity when compared with the activity of peripheral mono-
nuclear cells from non-pregnant or male individuals. The gestational age (7 to 20 weeks) of the pregnant
collective had no effects on peptidase levels. Women taking oral contraceptives had a slightly lower mean
activity than the non-pregnant group not using contraceptives. Thus, reduced dipeptidyl peptidase IV activity
of peripheral mononuclear cells might reflect impairement of cellülar immunity during pregnancy.
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mcrease of the level of B-cells (2-5), öthers could .
 x ^ ^ ^  * - ^ * ^
^ -
 4 . _ ,._ „ rrx xr .1 is an ectoenzyme which liberales dipeptides from thenot detect significant differences (6, 7). More recently · * r
variations of the T-cell subsets have been investigated ^
during pregnaiicy. Using monoclonal antibodies some ^ Enzymes; Dipeptidyl peptidase IV, dipeptidyl aminopepti-
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amino terminus of peptides or chromogenic Substrates
provided that the penultimate residue is a proline (11,
for review). Within the haemopoietic System, this pep-
tidase is only expressed on the plasma membrane of
T lymphocytes (12). About 10-60% of T-cells from
human peripheral blood bear this enzyme. Peptidase-
positive cells were found in both CD 4-1- and CD 8 +
lymphocytes (13). It has recently been shown that
CD 26 antigen is represented by the ectoenzyme di-
peptidyl peptidase IV (14). Expression on T lympho-
cytes was found to be associated with their capacity
to produce large amounts of interleukin 2 and to
proliferate strongly in response to mitogenic Stimu-
lation (13). Although this enzyme seems to play a role
during activation of T lymphocytes (15,16), its precise
biological function on lymphocytes is unknown. We
report here an approach to the quantitative evaluation
of the alterations of cell mediated immunity caused
by pregnancy, based on measurement of the dipeptidyl
peptidase IV activity of peripheral blood cells, thereby
taking advantage of the restricted specificity of this
enzyme.
Materials and Methods
Study collective
The blood donors were all healthy individuals who were class-
ified into four groups. Nineteen women with pregnancies rang-
ing from 7 to 20 weeks gestation with a mean age of 24.2 ± 5.4
years (r nge: 17—37 years), were compared against three con-
trol groups: 11 non-pregnant women taking oral contraceptives
(mean age 26.6 ± 4.6; r nge 22—38 years), 6 non-pregnant
women who were not using any contraceptives (mean age 28.2
± 8.1; r nge 22-44 years), and 10 males (mean age 32.4 ± 3.7;
r nge 25-38).
at 37 °C in a thermostatically regulated micro-cuvette. After
mixing 200 μΐ of the Suspension with washed peripheral mono-
nuclear cells (containing a measured number of lymphocytes
within the r nge 2—4 χ ΙΌ6 cells), the increase in absorbance
versus a blank (peripheral mononuclear cells replaced by salt
solution) was recorded at 405 nm for 15—20 min. Enzyme
activity was calculated from linear changes in absorbance with
time (usually reached after l —3 min) using molar absorbance
of 990 m2/mol for the liberated 4-nitrophenol. One unit (U)
corresponds to the release of l μιηοΐ 4-nitrophenol per min
under the above conditions. Measurements were made in tri-
plicate for each patient.
Statistical analysis
Normal distribution was checked by the Kolmogoroff-Smirnow-
test. Statistical differences between the groups were calculated
with the t- and a modified t-test (18).
Results
The dipeptidyl peptidase IV activities of peripheral
mononuclear blood cells from pregnant, non-preg-
nant and male individuals are summarized in table l.
For pregnant women with pregnancies of gestational
ages ranging between 7 to 20 weeks there were no
significant differences in the peptidase IV activity of
peripheral mononuclear cells. The mean activity level
for this group is therefore given s an Overall mean,
irrespective of gestational age. Individual dipeptidyl
peptidase IV values s well s the mean and media
catalytic activity concentration for each group is
shown graphically in figure 1. Differences between
the pregnant and all other groups are apparent and
can be sustained by Statistical analysis (t b. 1). The
most significant differences wero found between preg-
Lymphocyte preparation
Sterilized preservative-free sodium'heparin (50 IU/10 ml blood)
was placed in sterile polystyrol 16ml Falcon tubes (Becton
Dickinson, Heidelberg, Germany) into which 10ml of freshly
collected blood was immediately transferred and mixed. Human
peripheral mononuclear blood cells were isolated by a one Step
centrifugation over Lymphoflot (d = 1.077 kg/l Biotest,
Dreieich, Germany) after diluting the whole blood l: 2 with
Hank's balanced salt solution adjusted to pH 7.3. No attempts
were made to remove monocytes. The peripheral mononuclear
cells were washed twice with salt solution and following the
last centrifugation were resuspended in 700 μΐ salt solution. The
peripheral mononuclear cells concentration was then deter-
mined using a TOA Microcell counter (CC-108, Colora Me -
technik, Lorch, Germany). Enzyme activity of the Suspension
was determined within 3 h after Isolation.
Enzyme assay
Dipeptidyl peptidase IV activity was estimated spectrophotOr
metrically with Gly-Pro-4-nitranilide by a modification of the
procedure of Nagatsu et al. (17). One hundred microlitres of
2 mmol/1 Gly-Pro-4-nitranilide (Bachern, Bubendorf, Switzer-
land) in water, 100 μΐ of 0.5 mol/1 Tris/HCl-buffer, pH 8.0,
containing 5 mmol/1 EDTA and 600 μΐ water were prewarmed
Tab. l. Mean and median dipeptidyl peptidase IV activities of
human peripheral mononuclear blood cells.
Group Type Dipeptidyl peptidase Statistical
IV activity difference
(mU/106 cells) against
Mean ± SD Median P°pulationa)
I
II
Pregnant
Non-preg-
nant,
contracep-
tive
20
11
0.35
0.46
±
±
0.09
0.08
0.30
0.46
II,
I
III, IV
ni
IV
Non-preg- 6 0.53 ± 0.09 0.49
nant,
no contra-
ceptive
Male 18 0.44 ± 0.06 0.43
a) Statistical differences were calculated by using the t-test. The
significance level in all cases was atieast > 99% (I compared
* with III > 99.9%). According to the Kolmogroroff-Smirnow-
test normal distribution within the groups and .the total
collective is given at the 95% levfel.
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nant women and non-pregnant ones taking no con-
traceptive. Table l and figure l include only the data
from healthy individuals. Activities greater than 2
Standard deviations above the peptidase mean activity
of the pregnant group were found for a pregnant
woman (30th day of cycle) who aborted 4 days after
measurement (0.60 mU 10~6 peripheral mononuclear
cells), for a pregnant women after amnionocentesis
(16 weeks; 0.76 mU 10~6 peripheral mononuclear
cells), and for one with abdominal pains taking par-
acetamol (0.83 mU 10~6 peripheral mononuclear
cells). Within the non-pregnant group, values much
lower than the mean were obtained from a woman
(0.32 mU l O"6 peripheral mononuclear cells)
undergoing immunization against typhus and cholera
and from another woman with repeated bleeding
within a particular cycle (0.29 mU 10~~6 peripheral
mononuclear cells). It is therefore essential to carefully
screen individuals and to obtain follow-ups on the
outcome of pregnancy for example.
It is essential to ineasure the dipeptidyl peptidase IV
activity of peripheral mononuclear cells within 2—5 h
after purification. The cells should be stored at room
temperature, since a decrease in activity was observed
after storage at 4 °C. The coefficient of variance of
the enzymic test method was determined to be 10%.
The dipeptidyl peptidase IV activity of the serum was
completely removed from the peripheral mononuclear
cells by the washing procedure, since no activity could
be detected in the supernatant of the second wash. As
already repörted (12), lysis of peripheral mononuclear
cells with 1% Triton X-1ÖO does not increase the
peptidase activity, indicating that almost all activity
is expressed on the cell surface.
0.9 r
w
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>o.s
<u
0.3
0.1
Pregnant Non^pregnant Non-pregnant Males(contraceptives) (no contraceptives)
Fig. 1. Dipeptidyl peptidase IV activity of human peripheral
mononuclear blood cells from pregnant, non-pregnant
and male individuals (mean activity , median activ-
ity -—)·. The non-pregnant women are divided into
those taking oral contraceptives or no contraceptives.
Discussion
Glycyl-L-proline-4-nitranilideis hydrolysed by mono-
nuclear cells isolated from human blood exclusively
by dipeptidyl peptidase IV under the conditions em-
ployed (19). Dipeptidyl peptidase1) II, which competes
for the hydrolysis of this Substrate, is inhibited by the
slight alkaline pH and the presence of Tris during the
incubation (20); the only other proteases acting on
this Substrate, namely aminopeptidase P1) and prolyl
aminopeptidase1) by sequential action, are inhibited
by EDTA (11). Replacement of the above chromo-
genic substate by a fluorogenic one (-2-naphthylamide
or -4-methylcoumarin) increases the sensitivity, but
requires a stirred spectrofluorometer (21). It is essen-
tial to remove serum completely before measuring the
dipeptidyl peptidase IV activity of peripheral mono-
nuclear cells, since serum contains considerable activ-
ity. It is not known whether serum dipeptidyl pepti-
dase IV originales from lymphocytes, endothelial cells
of blood vessels or other tissues. However, serum
dipeptidyl peptidase IV activity is also reduced in the
first trimester of pregnancy (22).
Measurement of dipeptidyl peptidase IV activity of
peripheral mononuclear cells should reflect either the
number of circulating peptidase +/CD 26+ T lym-
phocytes or a Variation of the expression of this pro-
tein on the lymphocyte subset. Activity and antigen
expression appear to correlate (16). In clinical studies,
dipeptidyl peptidase IV immunoreactivity or activity
of peripheral mononuclear cells has been used äs a T
lymphocyte marker of leukaemias (19, 23) or human
immunodeficiency virus infections (24). As compared
with the variations foünd in these diseases or caused
by infections (this study), the reduction of dipeptidyl
peptidase IV activity of peripheral mononuclear cells
during pregnancy is rather low. Comparing the data
of non-pregnant women takiiig or taking not contra-
ceptives, peptidase activity on peripheral mononu-
clear cells appears to be hormonally influenced. How-
ever, provided that the dipeptidyl peptidase IV/CD
26 subset of lymphocytes or the increase of this
marker mirrors activated lymphocytes, äs suggested
by others (13 — 16), the decrease of peptidase activity
on peripheral mononuclear cells can be interpreted äs
a quantitative correlate for the depressed cellular im-
munity in pregnancy. Apart from this, dipeptidyl pep-
tidase IV on peripheral mononuclear cells appears to
be an interesting parameter for monitoring the Status
of cellular immunity in other diseases.
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